Development of a redox-related prognostic signature for predicting biochemical-recurrence-free survival of prostate cancer

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Oncology and Translational Medicine

• Publication date

  2023-04-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s10330-022-0594-4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• COL1A1 is a prognostic biomarker and correlated with immune infiltrates in lung cancer

  2021cited by this paper
• Oxidative Stress: A Key Modulator in Neurodegenerative Diseases

  2019cited by this paper
• Collagen 1A1 (COL1A1) Is a Reliable Biomarker and Putative Therapeutic Target for Hepatocellular Carcinogenesis and Metastasis

  2019cited by this paper
• Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer.

  2019cited by this paper
• TEX19 promotes ovarian carcinoma progression and is a potential target for epitope vaccine immunotherapy.

  2019cited by this paper
• Cancer statistics, 2019

  2019cited by this paper
• The RNA binding protein Ars2 supports hematopoiesis at multiple levels.

  2018cited by this paper
• Knockdown of arsenic resistance protein 2 inhibits human glioblastoma cell proliferation through the MAPK/ERK pathway

  2018cited by this paper
• The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy

  2017cited by this paper
• Human germ/stem cell-specific gene TEX19 influences cancer cell proliferation and cancer prognosis

  2017cited by this paper
• Re: Genomic Hallmarks of Localized, Non-Indolent Prostate Cancer.

  2017cited by this paper
• SLC transporters as therapeutic targets: emerging opportunities

  2015cited by this paper
• A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer.

  2015cited by this paper
• Integrative clinical genomics of advanced prostate cancer.

  2015cited by this paper
• Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.

  2015cited by this paper
• Prostate cancer in young men: an important clinical entity

  2014cited by this paper
• Mutant p53 in Cancer: New Functions and Therapeutic Opportunities

  2014cited by this paper
• Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies

  2013cited by this paper
• Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy

  2013cited by this paper
• Oxidative stress, inflammation, and cancer: how are they linked?

  2010cited by this paper
• G-CSF and its receptor in myeloid malignancy.

  2010cited by this paper
• Protein denitrosylation: enzymatic mechanisms and cellular functions

  2009cited by this paper
• Mapping and quantifying mammalian transcriptomes by RNA-Seq

  2008cited by this paper
• Redox Regulation of Cell Survival

  2008cited by this paper
• Free radicals and antioxidants in normal physiological functions and human disease.

  2007cited by this paper
• Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy.

  2007cited by this paper
• Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey.

  2007cited by this paper
• Role of oxidative stress in cardiovascular diseases

  2000cited by this paper

• The Mechanism of Oxidative Stress in Pulmonary Fibrosis and Research Progress

  2026cites this paper